TrialAntimicrobial agents and chemotherapy2025

SARS-CoV-2 resistance analyses from the Phase 3 PINETREE study of remdesivir treatment in nonhospitalized participants.

Lauren Rodriguez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.